-
Je něco špatně v tomto záznamu ?
Occurrence and prevention of Pickering foams in pharmaceutical nano-milling
R. Lehocký, D. Pěček, I. Saloň, F. Štěpánek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- biologická dostupnost MeSH
- farmaceutická technologie metody MeSH
- hydrofobní a hydrofilní interakce MeSH
- nanočástice chemie MeSH
- povrchově aktivní látky chemie MeSH
- roztoky chemie MeSH
- suspenze chemie MeSH
- velikost částic MeSH
- Publikační typ
- časopisecké články MeSH
Particle size reduction to sub-micrometer dimensions in stirred media mills is an increasingly common formulation strategy used for improving the bioavailability of poorly aqueous soluble active pharmaceutical ingredients (APIs). Due to their hydrophobic character, the API particles need to be stabilised by a surfactant in order to form a stable nano-suspension. This work is concerned with the understanding of an undesired phenomenon often encountered during the development and scale-up of wet nano-milling processes for hydrophobic APIs - the formation of foams. We investigate the microstructure, rheology and stability of these foams, and find them to be Pickering foams stabilised by solid particles at the gas-liquid interface rather than by a surfactant. By exploring the effect of surfactant concentration on the on-set of foaming in conjunction with the milling kinetics, we find a relationship between the specific surface area of the nano-suspension, the quantity of surfactant present in the formulation and the occurrence of foaming. We propose a mechanistic explanation of foam formation, and find that in order to prevent foaming, a large surfactant excess of approx. 100x above the critical micelle concentration has to be present in the solution in order to ensure a sufficiently rapid coverage of freshly exposed hydrophobic surfaces formed during the wet nano-milling process.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044570
- 003
- CZ-PrNML
- 005
- 20200114083103.0
- 007
- ta
- 008
- 200109s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejpb.2019.08.016 $2 doi
- 035 __
- $a (PubMed)31446043
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Lehocký, Róbert $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, Prague 6, 166 28, Czech Republic; Zentiva, k.s., U Kabelovny 130, Praha 10, 102 00, Czech Republic.
- 245 10
- $a Occurrence and prevention of Pickering foams in pharmaceutical nano-milling / $c R. Lehocký, D. Pěček, I. Saloň, F. Štěpánek,
- 520 9_
- $a Particle size reduction to sub-micrometer dimensions in stirred media mills is an increasingly common formulation strategy used for improving the bioavailability of poorly aqueous soluble active pharmaceutical ingredients (APIs). Due to their hydrophobic character, the API particles need to be stabilised by a surfactant in order to form a stable nano-suspension. This work is concerned with the understanding of an undesired phenomenon often encountered during the development and scale-up of wet nano-milling processes for hydrophobic APIs - the formation of foams. We investigate the microstructure, rheology and stability of these foams, and find them to be Pickering foams stabilised by solid particles at the gas-liquid interface rather than by a surfactant. By exploring the effect of surfactant concentration on the on-set of foaming in conjunction with the milling kinetics, we find a relationship between the specific surface area of the nano-suspension, the quantity of surfactant present in the formulation and the occurrence of foaming. We propose a mechanistic explanation of foam formation, and find that in order to prevent foaming, a large surfactant excess of approx. 100x above the critical micelle concentration has to be present in the solution in order to ensure a sufficiently rapid coverage of freshly exposed hydrophobic surfaces formed during the wet nano-milling process.
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a roztoky $x chemie $7 D012996
- 650 _2
- $a povrchově aktivní látky $x chemie $7 D013501
- 650 _2
- $a suspenze $x chemie $7 D013535
- 650 _2
- $a farmaceutická technologie $x metody $7 D013678
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pěček, Daniel $u Zentiva, k.s., U Kabelovny 130, Praha 10, 102 00, Czech Republic.
- 700 1_
- $a Saloň, Ivan $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, Prague 6, 166 28, Czech Republic.
- 700 1_
- $a Štěpánek, František $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, Prague 6, 166 28, Czech Republic. Electronic address: Frantisek.Stepanek@vscht.cz.
- 773 0_
- $w MED00001640 $t European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V $x 1873-3441 $g Roč. 143, č. - (2019), s. 91-97
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31446043 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200114083436 $b ABA008
- 999 __
- $a ok $b bmc $g 1482839 $s 1083243
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 143 $c - $d 91-97 $e 20190822 $i 1873-3441 $m European journal of pharmaceutics and biopharmaceutics $n Eur J Pharm Biopharm $x MED00001640
- LZP __
- $a Pubmed-20200109